In endometrial carcinoma, miR-29b expression simultaneously represses angiogenesis and tumorigenesis, both in vitro and in vivo, by negatively modulating VEGF expression and the mitogen-activated protein kinase (MAPK)/ERK and PI3K/AKT signaling pathways [94]. This evidence concerns the gene VEGFA and endometrial carcinoma.